1 – 10 of 37
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
- Impact of treatment delay in acute myeloid leukemia revisited
- Is there an impact of measurable residual disease as assessed by multiparameter flow cytometry on survival of AML patients treated in clinical practice? : A population-based study
-
Clinical and genomic characterization of patients diagnosed with the provisional entity Acute myeloid leukemia with BCR-ABL1, a Swedish population-based study
Orsmark-Pietras, Christina LU ; Landberg, Niklas LU
; Lorenz, Fryderyk
; Uggla, Bertil
; Höglund, Martin
; Lehmann, Sören
; Derolf, Åsa
; Deneberg, Stefan
; Antunovic, Petar
and Cammenga, Jörg
LU
, et al.
(2021)
In Genes, Chromosomes and Cancer
Mark
- Successful tyrosine kinase inhibitor discontinuation outside clinical trials — data from the population-based Swedish chronic myeloid leukaemia registry
- Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML : The HOVON-SAKK-132 trial
- 2020
- Hypo, Hyper, or Combo : New paradigm for treatment of acute myeloid leukemia in older people
- Introducing patient-reported outcome in the acute leukemia quality registries in Sweden
- The prognostic impact of FLT3-ITD and NPM1 mutation in adult AML is age-dependent in the population-based setting
- Real-world data on treatment patterns and outcomes of hypomethylating therapy in patients with newly diagnosed acute myeloid leukaemia aged ≥ 60 years
- Vitamin D levels and busulphan kinetics in patients undergoing hematopoietic stem cell transplantation, a multicenter study